Lodemann E, Lang M H, Oelmann R, Holzmann H
Zentrum der Biologischen Chemie, Universität Frankfurt.
Z Hautkr. 1990 Apr;65(4):404-6.
Both the serum levels of interferon and the activity of lymphocytic (2'-5')-oligoadenylate synthetase (OAS) of 37 patients suffering from malignant melanoma-15 with low (I,I-II,II) and 22 with higher (III,IV,V) Clark levels-were compared with those of a group of healthy controls in order to detect a possible involvement of the interferon system in the pathological process. Previous results obtained in studies on relatively small groups of patients had suggested that melanoma patients with low Clark levels (i.e. biologically early melanoma) show elevated activities of OAS, while those with higher levels show normal values. In our present investigation on a larger sample of patients, we did not find any differences between these two melanoma groups and healthy persons with regard to the OAS activity. Thus we were not able to confirm the provisional results set up by previous studies.
为了检测干扰素系统是否可能参与病理过程,对37例恶性黑色素瘤患者(15例Clark分级为低级别(I、I-II、II级),22例为高级别(III、IV、V级))的血清干扰素水平和淋巴细胞(2'-5')-寡腺苷酸合成酶(OAS)活性与一组健康对照者进行了比较。先前在相对较小患者群体的研究中获得的结果表明,Clark分级为低级别(即生物学早期黑色素瘤)的黑色素瘤患者OAS活性升高,而高级别患者的OAS活性值正常。在我们目前对更大患者样本的研究中,我们未发现这两组黑色素瘤患者与健康人在OAS活性方面存在任何差异。因此,我们无法证实先前研究所确立的初步结果。